Annual report pursuant to Section 13 and 15(d)

Note 14 - Stock-based Compensation - Valuation Assumptions (Details)

v3.22.4
Note 14 - Stock-based Compensation - Valuation Assumptions (Details) - $ / shares
12 Months Ended
Nov. 30, 2022
Nov. 30, 2021
Maximum [Member]    
Market price of the Company’s common stock on date of grant (in dollars per share)   $ 26.9
Minimum [Member]    
Market price of the Company’s common stock on date of grant (in dollars per share)   $ 20.9
Share-Based Payment Arrangement, Option [Member]    
Risk free rate 3.34% 0.30%
Expected dividends 0.00% 0.00%
Expected volatility 78.44% 92.00%
Expected life (in years) (Year) 6 years 6 months 3 years
Market price of the Company’s common stock on date of grant (in dollars per share) $ 5.51  
Exercise price (in dollars per share) $ 7.70  
Share-Based Payment Arrangement, Option [Member] | Maximum [Member]    
Risk free rate 3.35% 0.64%
Expected dividends 0.00%  
Expected volatility 70.00% 113.00%
Expected life (in years) (Year) 1 year 4 months 20 days 5 years
Market price of the Company’s common stock on date of grant (in dollars per share) $ 8.24 $ 20.94
Exercise price (in dollars per share)   $ 20.20
Share-Based Payment Arrangement, Option [Member] | Minimum [Member]    
Risk free rate   0.26%
Expected volatility   80.00%
Expected life (in years) (Year)   4 years
Market price of the Company’s common stock on date of grant (in dollars per share) $ 7.69 $ 14.74
Exercise price (in dollars per share)   $ 14.90